racle Forms Health And Sciences Business Unit
The News Review:
- racle Forms Health And Sciences Business Unit
- Despite suspension Hopkins researchers continue vital tests
- Home Blood Pressure Monitoring Plus Web-based Pharmacy Care Helps…
- Canada’s Med-pot Hot or Not?
racle Forms Health And Sciences Business Unit
InformationWeek – Jun 24, 2008
The business unit’s offerings will expand by “organic” development as well as through possible acquisition of and partnerships with third-party clinical application vendors whose products “integrate” into racle’s platform he says. racle also disclosed that among recent health and life sciences sector customers is Indian clinical research organization Siro Clinpharm Private which conducts clinical trials for the pharmaceutical biotech and medical device industries. Siro Clinpharm says it’s using a number of racle’s clinical applications for “end-to-end” clinical research according to a statement released by the companies.
Despite suspension Hopkins researchers continue vital tests
Baltimore Sun – Jun 24, 2008
Some of the cases included a man with diabetes who needed an implantable insulin pump refilled and a pregnant woman with a genetic disorder who was on a special diet. Christopher Saudek director of the General Clinical Research Center at Hopkins said the patients would have been harmed if their studies had been stopped. In pediatrics doctors worried over a baby with a rare metabolic disease for whom the only treatment is an experimental drug. "There was no doubt in my mind that there would have been significant risk of damage to this child's liver and brain if the experimental therapy was stopped last night" said Dr. George Dover director of the Hopkins' Children's Center. Dover walked the halls of the pediatric wards until midnight Thursday talking to patients doctors and nurses trying to assure them that every patient would still get the care they needed.
Home Blood Pressure Monitoring Plus Web-based Pharmacy Care Helps…
Science Daily – Science Daily (press release) – Jun 24, 2008
of the Duke Clinical Research Institute Durham N. and Contributing Editor JAMA comment on the findings of Green and colleagues.
Canada’s Med-pot Hot or Not?
AlterNet – Jun 24, 2008
Brent Zettl the company’s co-founder says that the crop came out even better than he had hoped. “It is not easy to build a 12000 square foot chamber deep in a mine get it security cleared and then produce a crop that meets the contract obligations in stellar quality within 12 months” Zettl told Cannabis Culture. riginally Prairie Plant only intended to produce cannabis for clinical research but that plan changed when their specialized growing techniques produced way more than the clinical trials could use partly because the number of approved clinical trials was smaller than expected. As pot from Prairie Plant gets ready to hit the market it has been besieged by a wide range of critics including patients compassion clubs and competitors. “ne thing it does is set the expectation pretty low which gives us an opportunity to excel” said Zettl. “We have been criticized for not knowing what we are doing with this particular plant despite the fact that we have a corporate resume that looks at well over 3000 different species of plants. We’ve had to figure out way harder things with way less information going in.
Written by admin on June 24th, 2008 with
no comments.
Read more articles on News.